Qiagen N.V. (QGEN)

NYSE · Healthcare · Diagnostics & Research
$49.30-0.66%As of 2026-11-22 · USD
Last session low $49.27Last session high $49.61
52-week low $32.5352-week high $57.82
Market cap
$10.18B
Sector
Healthcare
P/E (TTM)
26.6x
Dividend yield
0.71%
Next earnings
2027-02-03 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)54.5In the neutral range (30 to 70)
MACD (12, 26, 9)0.61Below its signal line (0.94); histogram -0.33
Bollinger %B (20, 2)-8%Below the lower band (49.42 to 50.95)
SMA 2050.19Price is 1.8% below
SMA 5047.21Price is 4.4% above
SMA 20042.39Price is 16.3% above
ATR (20)1.38% of priceAverage true range per day
52-week position66%In the middle of the 32.53 to 57.82 range

About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Latest fiscal yearEnded 2025-12-31: revenue of $2.09B and an operating margin of 24.9%.
Next earnings reportExpected on 2027-02-03 (the date is an estimate).

More in Diagnostics & Research